terns between the right and left gonad and that the pattern of methylation in female gonads was not affected by sex reversal. However, we did find an unexpected window where MHM promoter methylation levels were very low in both males and females. This developmental window coincided with a stage of gonad development where there is a dramatic increase in expression of key testis genes in males and of key ovary genes in females. The current study raises the possibility that the non-coding RNA transcripts of MHM may affect testis and ovary differentiation by influencing sex-specific gene expression.
1951], a time when the gonads in male and female embryos are indistinguishable from each other. From this point onwards, testis or ovary differentiation proceeds, and by HH36, the gonads in males and females are distinctly different. In the male embryo the gonads adopt a tubular form and right and left gonads are similar in appearance. In the female embryo the gonads initially appear similar to those in males, but the right gonad ceases to develop and the left gonad adopts a broader flatter appearance and is markedly larger than the right gonad. As gonadal sex differentiation progresses, the morphological differences between left and right gonads in the female become more pronounced, while the left and right male gonads remain similar in appearance throughout embryonic development [Guioli et al., 2014] .
Chicken tissues have been shown to possess a cell autonomous sex identity [Zhao et al., 2010; Garcia-Morales et al., 2015] , but how this sex identity impinges on the mechanisms regulating sex determination and differentiation is still unclear [Lambeth et al., 2016] . The sex (gonadal) determining mechanism in birds is thought to depend on either (a) expression of a W chromosome encoded ovary-determining gene, akin to SRY in mammals or (b) the dosage of a Z chromosome encoded gene (or genes) with higher expression levels in males than in females [Smith and Sinclair, 2004; Zhao et al., 2010; Clinton et al., 2012; Lambeth et al., 2016 ]. An avian homologue to the SRY gene does not exist and, so far, efforts to identify a suitable candidate ovary-determining gene have been unsuccessful [Teranishi et al., 2001; Smith et al., 2009a] . On the other hand, of the more than 800 genes mapped to the Z chromosome [Nanda et al., 1999 [Nanda et al., , 2000 (http:// www.ensembl.org/index.html), the DMRT 1 gene (doublesex and mab-3 related transcription factor 1) is considered to be a prime candidate for a factor underlying a dosage-based mechanism [Clinton et al., 2012; Cutting et al., 2013; Garcia-Morales et al., 2015; Lambeth et al., 2016] . In chicken embryos, DMRT1 expression is restricted to the gonads and is first detectable in the genital ridge around the time of sex determination, with higher expression level in males (ZZ) than in females (ZW). In addition, DMRT1 expression is increased in the gonads of female embryos that have been sex-reversed by fadrozole treatment [Smith et al., 2003 [Smith et al., , 2009b Smith and Sinclair, 2004; Ayers et al., 2015] . These findings have led to the suggestion that the key factor in avian sex determination is the dose of DMRT1.
The DMRT1 locus on the Z chromosome is located adjacent to a second region with sex-specific characteristics, the MHM (male hypermethylated) region. This locus transcribes a Xist-like long non-coding RNA, and although males have 2 genomic copies and females only 1, transcripts from this region are expressed only in female chickens. The male Z chromosomes are hypermethylated in this region, while the single female Z chromosome is hypomethylated [Teranishi et al., 2001] . The MHM region comprises around 200 repeats of a 2.2-kb sequence that generates a non-coding RNA that accumulates at the site of transcription in the female nucleus. Interestingly, this female-specific expression (and male silencing) of MHM is established within the first day following fertilization [Teranishi et al., 2001] . It has been suggested that this transcript has an epigenetic role in silencing of DMRT 1 expression in female cells in order to suppress male gonadal development [Ellegren, 2002; Mizuno et al., 2002; Roeszler et al., 2012; Caetano et al., 2014] . The relationship, if any, between methylation levels of MHM and the expression profiles of genes associated with gonadal development has yet to be determined.
The objective of the current study is to establish the MHM methylation pattern during chicken gonadal development and to determine how this pattern correlates with the expression profiles of genes involved in sex determination and gonadal differentiation.
Materials and Methods

Animals and Samples
Fertilized eggs from single-comb White Leghorn chicken were incubated under standard conditions (temperature 37.8 ° C, relative humidity 65%). On day 3 of incubation at HH18, eggs were randomly divided into either untreated or Fadrozole-treated groups. The eggs in the fadrozole treatment group were injected with a solution containing 1.0 mg fadrozole (Novartis) in PBS. Following injection, the holes were sealed with paraffin as described previously [Yang et al., 2008] , and eggs were reincubated until the appropriate collection time point.
For DNA methylation profiling, gonads and breast muscles were collected from 5 male and 5 female embryos from each group and developmental stage. A portion of muscle tissue was used for genetic sex identification [Clinton et al., 2001; Yang et al., 2008] . For RNA extraction, the gonads were harvested from 20 male and 20 female White leghorn chicken embryos and used to generate pools containing 5 gonad pairs each.
RNA and DNA Extraction RNA was extracted from chicken embryo gonads as described previously [Yang et al., 2010] . Briefly, total RNA was isolated using TRIzol reagent (Invitrogen) and treated with RNase-free DNase I to eliminate possible genomic DNA contamination. RNA quality and quantity was estimated by gel electrophoresis and by spectrophotometric analysis at 260 and 280 nm.
Genomic DNA was isolated from chicken embryo gonads using the TIANamp Micro DNA Kit (Tiangen, Beijing, China), and the quality and quantity were estimated by amplification of the CHD1 gene. Genomic DNA for sex identification was purified from muscles by standard phenol-chloroform extraction.
Sodium Bisulfite Cloned Sequencing
The full MHM region of single-comb White Leghorn was amplified and sequenced as described previously [Yang et al., 2011] . The CpG islands in the MHM sequence were predicted using an online software (http://www.urogene.org//methprimer/index1. html). Under conditions of Obs/Exp = 0.8, GC% = 50, cMHM was predicted to contain only 1 CpG island. Primers flanking the CpG island were designed using oligo6.0 software and were synthesized in Sangon (Sangon). The primer sequences were as follows: S1-F 3 ′ -AGATTGTTGGTTTTGTATTTTTGTG-5 ′ , S1-R 3 ′ -AATTC-TTTACTCCTTTAAAAACCCC-5 ′ and generated a 280-bp PCR product.
DNA methylation was analyzed by bisulfite-assisted genomic sequencing procedures [Hajkova et al., 2002] . Genomic DNA was modified using the CpGenome TM DNA Modification Kit S7820 (Chemicon) following the recommended protocol.
The PCR annealing temperature was optimized using a gradient PCR cycler (Bio-Rad). The PCR reaction comprised of 0.5 μg genomic DNA modified with bisulfite, 1× PCR buffer (10 m M TrisHCl pH 8.3, 1.5 m M MgCl 2 , 50 m M KCl), 0.2 m M dNTPs, 0.2 μ M each of primers, 0.5 U of LA Taq TM DNA Polymerase (Sangon), and ddH 2 O to a final volume of 25 μl. PCR reaction conditions were 95 ° C for 3 min, followed by 39 cycles at 95 ° C for 20 s, 55 ° C for 30 s, 72 ° C for 30 s, and a final extension at 72 ° C for 10 min. The amplified products were separated by 2.0% agarose electrophoresis and purified by TIANquick Midi DNA Purification kit (Tiangen). The purified targeted products were cloned into pMD18-T (Takara) and the recombinant plasmid transformed into E.coli DH5α. Positive clones containing the targeted fragment were verified by PCR amplification and sequencing. The percentage of DNA methylation in the selected CpG island of cMHM was calculated.
Quantitative Real-Time PCR Primers for quantitative PCR were designed using Primer Express Software v3.0 from Applied Biosystems and obtained from Sangon. Primer sequences and assay details for AMH , FOXL2 , SOX9 , P450arom , DMRT1 , ERα , and β-actin are as previously reported [Yang et al., 2010] . First strand cDNA was synthesized using 0.4 μ M oligo(dT)18, 1 μg of total RNA, 1× buffer (10m M TrisHCl pH 8.3, 50 m M KCl, 5 m M MgCl 2 ), 1.2 m M dNTPs, 1.6 U RNase-inhibitor, and 8 U M-MLV (Promega) in a 25 μl reaction volume. Reverse transcription (RT) conditions were 25 ° C for 10 min, 37 ° C for 1 h, followed by inactivation by heating to 95 ° C for 5 min. Effective cDNA synthesis was confirmed by β-actin PCR.
Real-time PCR was carried out in an ABI PRISMR 7300 HT Quantitative PCR System (Applied Biosystems) following the machine's default cycling protocol. The SYBR ® Green PCR master mix (Applied Biosystems) was used in a 15 μl reaction volume as follow: 7.5 μl SYBR ® Green Master Mix (2×), 1.0 μl for each primer (1 μ M ), 1.0 μl cDNA (diluted 10×), and 4.5 μl ddH 2 O. Negative controls used ddH 2 O in place of cDNA in PCR reactions. The specificity of amplified products was determined by melting curve analysis, agarose gel electrophoresis, and sequencing. Values for each reaction were normalized against β-Actin transcript levels. Fig. 1 . MHM methylation. a MHM methylation levels in right and left gonads from male and female chicken embryos and in gonads from fadrozole-treated female embryos. For each gonad type, MHM levels are shown at different developmental stages from HH29 to HH40. At most time points, levels of methylation are higher in male gonads than in female gonads and in fadrozoletreated female gonads. Levels of methylation are significantly lower at HH34 than at any other time point and are not different between male and female gonads. There is no significant difference between methylation profiles in left and right gonads. b MHM methylation levels in skeletal muscle from male and female chicken embryos at HH29, HH34, and HH36. There is no significant difference in MHM methylation levels in male and female muscle and no drop in the methylation level seen at HH34.
Results
MHM Methylation during Gonadal Development
Details of the MHM CpG island and of the methods used in this study have been reported previously [Yang et al., 2011] . Briefly, a 280-bp PCR product of the region surrounding the MHM CpG island was amplified, and DNA methylation patterns of the MHM amplicon were analyzed by bisulfite-assisted genomic sequencing. For each sample type, 10 separate clones were sequenced and the average methylation level calculated. The level of CG methylation of the MHM amplicon in the gonads of untreated embryos and fadrozole-treated embryos at different developmental stages and methylation levels in male and female skeletal muscle tissue are shown in figure1 a and b, respectively.
In skeletal muscle, methylation levels were similar at all developmental stages tested and were not significantly different between male and female embryos. In contrast, significantly higher MHM methylation levels were found in untreated male gonads than in female gonads at HH stages 29, 36, and 40 (p < 0.05). This male:female difference in methylation levels was seen in both right and left gonads. Most interestingly, methylation levels at HH34 were lower than those at other developmental time points, and there was no difference in the level of methylation Gene expression in male ( a ) and female ( b ) chicken gonads at different stages of development. Expression of DMRT1 , SOX9 , and AMH is higher in male gonads than in female gonads, while expression of FOXL 2 and P450arom is higher in female gonads than in male gonads. The expression level of estrogen receptor is similar in male and female gonads. Sex-enriched transcripts show a dramatic increase in expression levels at HH34.
between male and female gonads. Fadrozole treatment of female embryos, which results in the gonads developing as testes, had no effect on the pattern or levels of methylation.
Expression of Sex-Related Transcripts
Quantitative real-time PCR (qRT-PCR) was used to measure the levels of DMRT 1, SOX9 , AMH , P450arom , FOXL 2, and ER α in male and female gonads at different stages of development. DMRT1, SOX9, and AMH are known to be expressed at higher levels in male than female gonads, while P450arom and FOXL2 have been shown to be female-specific. ERα is expressed at similar levels in male and female gonads. On the basis of our qRT-PCR analyses, all of the transcripts monitored here displayed the expected expression patterns ( fig. 2 ) .
In the period immediately following sex determination, only very low levels of gene expression are evident (HH28 and HH30: day 5.5-7.0 of incubation). However, at HH34, there is a significant increase in the relative expression levels for both the male-enriched transcripts in the testis (DMRT1, SOX9, AMH) and the female-enriched transcripts in the ovaries (P450arom, FOXL2) (p < 0.05).
Discussion
Our study shows that the MHM promoter is hypermethylated in skeletal muscle during embryonic development and that there are no significant differences between the methylation levels in male and female muscle. In contrast, and in agreement with previous reports, our analysis showed a significant difference in MHM methylation levels between male and female gonads at various stages of development. The only exception to this pattern was seen in gonads at HH34 where very low levels of methylation were observed in both male and female embryos. The methylation levels found at HH34 in both males and females were even lower than those seen in female gonads at other developmental stages studied.
There was no difference in methylation levels between left and right female gonads, even at stages when there are clear morphological differences between the 2 sides. Fadrozole treatment, which transforms both of the developing female gonads into testes, had no effect on methylation levels and resulted in methylation profiles indistinguishable from those of untreated female embryos.
The current study also analyzed the expression of a number of genes that are known to be expressed in a sexually dimorphic manner during gonadal development in the chicken. All of the genes studied showed the expected sexually dimorphic expression patterns. However, it is interesting to note that, coincident with the 'valley' in MHM methylation ( fig. 3 ) , the 'male-enriched' genes (DMRT1, SOX 9 , AMH) all showed a significant increase in expression in the developing testis and the 'female-enriched' genes (FOXL2, P450arom) showed a significant increase in expression in the developing ovary.
Previous studies have reported sexually dimorphic MHM methylation patterns in the embryonic chicken gonads and female-specific expression of the MHM transcript [Teranishi et al., 2001; Bisoni et al., 2005; Melamed and Arnold, 2007; Roeszler et al., 2012] . These studies have suggested that the functional products of the MHM locus might participate in the regulation of chicken gonadal differentiation and/or the avian dosage compensation mechanism. Our analyses also found a similar sexually dimorphic MHM methylation pattern, but in addition, we identified a developmental window in which methylation levels of MHM are extremely low in both male and female gonads. This raises the possibility of 2 distinct roles for MHM; one that is sexually dimorphic and requires different methylation levels in males and females and a second role that is common to males and females and involves a short period of hypomethylation of the MHM promoter. It is intriguing that the window of low MHM methylation coincides with a significant increase in the expression of important regulatory genes. While DMRT1 is considered by most to be the testis-determining gene in birds, Dmrt1, Sox9, and Amh have also Fig. 3 . Schematic illustrating MHM methylation levels associated with gonadal development in male chicken embryos. The MHM CpG island shows a 'valley' in methylation levels in the developing testis at HH34 that is coincident with both the lowest methylation levels found in the developing ovary and with a dramatic increase in expression of key genes required for gonadal differentiation.
been shown to play a role in Sertoli cell differentiation and function in the mouse [Sekido and Lovell-Badge, 2007; Matson et al., 2011; Lindeman et al., 2015; . In addition, FOXL2 and P450arom are known to play key roles in ovarian differentiation and function in birds and mammals [Chue and Smith, 2011; Gong et al., 2012] . Whatever the role of MHM, it is unlikely to be related to morphological changes per se as there is no difference in methylation patterns between left and right female gonads. It also seems likely that the effect is cell autonomous and hormone independent, as methylation patterns are not affected by fadrozole-based sex reversal. Perhaps the window of low MHM methylation levels enhances the transcription of genes with gonad-specific expression patterns?
It is also interesting to note that the MHM methylation 'valley' seen in male and female gonads at HH34 is reminiscent of hypomethylation of the Sry promoter seen in the mouse at the time of sex determination [Nishino et al., 2004] . It is well established that Sry expression is essential for initiating the gene expression cascade leading to testicular differentiation in mammals, and that during mouse development, Sry expression is restricted to gonadal somatic cells at 10.5-12.5 days post-coitum Koopman et al., 1990; Sinclair et al., 1990; Mitchell et al., 1991] . Intriguingly, in the mouse gonad, the Sry promoter region is hypermethylated prior to the period of expression and hypomethylated during the expression period [Nishino et al., 2004] .
In conclusion, we found an unexpected window of MHM DNA demethylation in the gonads at HH34, a time when there is a significant increase in transcriptional activity of testis specific genes in male embryos and ovary specific genes in female embryos. It may be that the noncoding MHM RNAs affect gonadal differentiation by influencing sex-dependent gene expression.
